Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianbao Lu

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Rheumatology|September 16, 2017
Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytesTianbao Lu, Ming Zong, Shasha Fan, et al.
Arthritis Research & Therapy|April 19, 2015
Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritisMing Zong, Tianbao Lu, Shasha Fan, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitorsLily Lee, Kevin D Kreutter, Wenxi Pan, et al.
Oncotarget|March 23, 2016
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLCYueyu Cao, Mengdan Wei, Bing Li, et al.
Chemical Biology & Drug Design|April 14, 2006
Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interactionMaxwell D Cummings, Carsten Schubert, Daniel J Parks, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitorsBruce Tomczuk, Tianbao Lu, Richard M Soll, et al.
Chemical Biology & Drug Design|August 23, 2006
Exploration of potential prodrugs of RWJ-445167, an oxyguanidine-based dual inhibitor of thrombin and factor XaBruce E Maryanoff, David F McComsey, Michael J Costanzo, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesisTianbao Lu, Thomas Markotan, Frank Coppo, et al.
Journal of Medicinal Chemistry|February 18, 2005
Design, synthesis, and biological evaluation of novel potent and selective alphavbeta3/alphavbeta5 integrin dual inhibitors with improved bioavailability. Selection of the molecular coreJuan José Marugán, Carl Manthey, Beth Anaclerio, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2006
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activityKristi Leonard, Juan Jose Marugan, Pierre Raboisson, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Rheumatology|September 16, 2017
Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytesTianbao Lu, Ming Zong, Shasha Fan, et al.
Arthritis Research & Therapy|April 19, 2015
Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritisMing Zong, Tianbao Lu, Shasha Fan, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2007
2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitorsLily Lee, Kevin D Kreutter, Wenxi Pan, et al.
Oncotarget|March 23, 2016
Functional role of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in NSCLCYueyu Cao, Mengdan Wei, Bing Li, et al.
Chemical Biology & Drug Design|April 14, 2006
Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interactionMaxwell D Cummings, Carsten Schubert, Daniel J Parks, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Oxyguanidines: application to non-peptidic phenyl-based thrombin inhibitorsBruce Tomczuk, Tianbao Lu, Richard M Soll, et al.
Chemical Biology & Drug Design|August 23, 2006
Exploration of potential prodrugs of RWJ-445167, an oxyguanidine-based dual inhibitor of thrombin and factor XaBruce E Maryanoff, David F McComsey, Michael J Costanzo, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2004
Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesisTianbao Lu, Thomas Markotan, Frank Coppo, et al.
Journal of Medicinal Chemistry|February 18, 2005
Design, synthesis, and biological evaluation of novel potent and selective alphavbeta3/alphavbeta5 integrin dual inhibitors with improved bioavailability. Selection of the molecular coreJuan José Marugán, Carl Manthey, Beth Anaclerio, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2006
Novel 1,4-benzodiazepine-2,5-diones as Hdm2 antagonists with improved cellular activityKristi Leonard, Juan Jose Marugan, Pierre Raboisson, et al.
Pageof 3